Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

Ekso Bionics Holdings, Inc. (EKSO)

Add EKSO Price Alert      Hide Sticky   Hide Intro
Moderator: mick, makingbiigdough, skepticone, Rhetorical
Search This Board: 
Last Post: 11/17/2017 9:40:18 PM - Followers: 96 - Board type: Free - Posts Today: 0

Industry leaders in healthcare, military, and industrial exoskeletons 
                                         (Continue below to message board)                                  


Ekso GT (Healthcare):

Ekso GT is a robotic exoskeleton used for over-ground gait training in people with a neurological diagnosis. It helps patients re-learn the correct step patterns and weight shifts involved in walking, potentially mitigating compensatory behaviors.

Ekso GT’s Variable Assist software allows physical therapists to determine how much power is provided to either side of the person’s body. This balances the physical effort that the person exerts with the amount of help that he or she needs to achieve a more normalized gait. It also makes the device suitable for a broad spectrum of neuro-rehabilitation activities and keeps individuals challenged as they progress through their rehabilitation.

For people who thought they would never stand or walk again, Ekso GT provides hope for greater mobility and independence.

[Christina Kwasnica, M.D., medical director for the Barrow Neuro Rehabilitation Center, notes, “The robotic device allows us to get patients up on their feet earlier. The gains we see are overwhelming and the positive effects on a patient’s mood and motivation is unbelievable.”

Ekso Bionics(TM) Receives Its First NIH Grant (Oct 28, 2014):
RICHMOND, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.

Ekso Bionics Licences Intellectual Property to Ottobock (Nov 3, 2014):

Ekso GT™ Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients (Apr 4, 2016):

EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology (Jun 7, 2016):

Ekso Bionics® Launches Smart Assist (Oct 4, 2016):

Ekso Bionics® Launches EksoPulse Cloud-Based Analytics (Feb 9, 2017):

Ekso Bionics and Vodafone Receive 2016 HealthTechZone Telehealth Award (Apr 7, 2017):

Ekso: T.A.L.O.S. & Warrior Web (D.O.D.):

T.A.L.O.S. (Tactical Assault LIght Operator Suit):
Ekso Labs was awarded an Other Transaction for Prototypes Agreement from U.S. Special Operations Command (SOCOM) to develop technologies for their Tactical Assault Light Operator Suit (TALOS) project. TALOS is a futuristic assault suit that promises to provide superhuman strength with superior mobility and protection, and is often referred to as the "Iron Man" suit. The exoskeleton chassis, which Ekso Labs is developing, will be designed to allow soldiers to carry out their mission with agility, while carrying hundreds of pounds of load. The TALOS project is integrating other functional elements, including armor and systems, to provide situational awareness and technology for vital signs monitoring.

Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project

Ekso(TM) Labs Secures Third Contract With the U.S. Special Operations Command (SOCOM) for Upper Extremity TALOS Project (5/20/15)

Warrior Web Flexible Exoskeleton:
Ekso Bionics™ Selected for Development of Next-Generation DARPA Exoskeleton

Warrior Web A:
Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported.

Warrior Web B:

"Ekso Bionics (NASDAQ: EKSO), having successfully supplied technology to Warrior Web Task A, has been selected to participate in the second and concluding Warrior Web Task B.

Ekso Bionics will gain $4.5 million in the combined contract for both tasks." - RBR

Army R&D with RE2 Robotics:
(This is from a press release from RE2, not from Ekso Bionics. Ekso is simply jointly involved as mentioned below)
Note: EKSO is now on the NASDAQ exchange not the OTCBB

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."


EksoZeroG and Artemis (Construction/Tool Usage):


Ekso Bionics has spent several years designing and perfecting a range of ergonomic tool arms which are used to weightlessly manoeuvre heavy tools. These arms rely on spring tension and innovative design to balance the weight of tools used in drilling, sanding, riveting and many other applications. The Ekso Bionics Zero G arms are designed to hold loads of up to 19kg and fully balance the weight thus allowing the user to freely, safely and accurately manoeuvre the load in any direction without injury or fatigue.

The ergonomic tool arms have a variety of mounting options to suit the application including portable gantry’s, carts, jib arms, and linear rail. These systems require very little maintenance, no expensive inputs like electricity or compressed air, and have already been successfully used in a variety of industries from aerospace and defence to automotive manufacturing.

  • -Payback of less than a year
    -ROI of 100%
    -Less than 30 min of operator training required to achieve competency
    -No expensive inputs such as electricity or air required
    -Very minimal maintenance
    -Modular design for flexibility
    -13 different mobile and fixed mounting options
    -4 different arm configurations

There are several mounting options fro the Zero G ergonomic tool arms from ground based trolleys, to gantry mounts, jib crane mounts, linear rail and bench top mounting.

The Zero G ergonomic tool arm is used extensively in the aerospace,construction, mining and ship building industries in a range of roles. The weight balancing aspect of the Equipois Zero G system allows workers to grind, drill, chip surfaces easily for long periods of time even if the surface is in an overhead orientation.

Current users of the Equipois Zero G system include Airbus, Boeing, General Electric, BHP Billiton, Gammon Construction, Lockheed Martin, Chrysler, Ford, Honda, Nissan, Toyota, Caterpillar, John Deere, Bradken and many more.


Ekso Artemis:

"RICHMOND, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an exoskeleton company, today announced that it has completed the development of a lightweight, flexible load carriage exoskeleton prototype named Artemis."

Ekso Bionics Company Information:
-Founded in 2005 and headquartered in Richmond, CA 
--Originally Berkely Bionics of Univsity of California, Berkeley
-The current CEO is Thomas Loobyy
-Ekso is the industry leader in healthcare, military, and industrial exoskeletons
-The Ekso Bionics Ekso GT™ is the first and only FDA approved exoskeleton for stroke rehabiliation
-Over 190 international patent cases (granted or pending)

-Headquartered in the historic Ford Motor Company Assembly Plant, the largest wartime production assembly plant to be built on the West Coast
Company Presentation:

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested. There are no guarantees when buying or selling any security.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EKSO News: Consolidated Research: 2018 Summary Expectations for Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Comm... 11/16/2017 08:15:00 AM
EKSO News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 11/13/2017 05:01:38 PM
EKSO News: Quarterly Report (10-q) 11/08/2017 04:38:09 PM
EKSO News: Current Report Filing (8-k) 11/08/2017 04:10:50 PM
EKSO News: Ekso Bionics Reports Third Quarter 2017 Financial Results 11/08/2017 04:05:00 PM
#2381  Sticky Note On Talos: [continued "top level support" for the Rhetorical 08/16/16 07:02:33 PM
#1234  Sticky Note $EKSO recent news/filings RECENT NEWS 02-03-16 1 MIL. GRANT mick 02/04/16 11:05:48 AM
#3988   Cup with handles (chart formation) at 5$ is Rhetorical 11/17/17 09:40:17 PM
#3987   This was $4.90 back in last all shotgun 11/17/17 08:52:45 PM
#3986   EKSO getting bought up in after hours. RLBTrader 11/17/17 06:57:53 PM
#3985   Good moves last couple weeks. Will it continue? radly 11/17/17 06:16:41 PM
#3984 Rhetorical 11/17/17 05:33:56 PM
#3983 Rhetorical 11/17/17 05:29:00 PM
#3982   Nice chart w/ 30 minute candlesticks! See Implied Rhetorical 11/17/17 05:28:41 PM
#3981   * * $EKSO Video Chart 11-17-17 * * ClayTrader 11/17/17 04:57:28 PM
#3980   Huge.. if this company's awareness starts driving orders, formerdtrader 11/17/17 11:33:11 AM
#3979   CEO was on Fox Business this morning showing RainerRocks 11/17/17 10:55:17 AM
#3978   $3 coming here Trons 11/16/17 02:56:19 PM
#3977   I think since there was no revenue or golfblues 11/16/17 10:33:34 AM
#3976   From there Facebook page... skepticone 11/16/17 09:36:59 AM
#3975   I know that by now everyone has seen skepticone 11/16/17 09:29:24 AM
#3974   And the other way around. No coincidence they Dubi1979 11/15/17 11:13:43 PM
#3972   I was once where you are. My original skepticone 11/15/17 08:47:20 PM
#3971   I wrote that post when I saw the skepticone 11/15/17 08:28:38 PM
#3970   Why do I have that feeling I've been golfblues 11/15/17 03:46:59 PM
#3969   could be looks like it want to berta 11/15/17 10:40:00 AM
#3968   Looks like we are headed south toward 1.40-ish skepticone 11/15/17 08:39:33 AM
#3967   Spot on from the article. Give them another golfblues 11/14/17 05:39:25 PM
#3966   Just some interesting reading...also check out the the skepticone 11/14/17 03:50:41 PM
#3965   I believe the 43 is a typo, if skepticone 11/14/17 03:38:17 PM
#3964   I’d take the point after the 43 but Lion33 11/14/17 02:11:44 PM
#3963   The article says 43 for the one year radly 11/14/17 01:28:25 PM
#3962   I have to believe that was a typo golfblues 11/14/17 01:23:19 PM
#3961   Nice to see but $43 for a one Lion33 11/14/17 12:05:56 PM
#3960   Well if that's the case, great, but you golfblues 11/14/17 11:57:19 AM
#3959 radly 11/14/17 11:32:07 AM
#3958   Have you read the reasons for the increase? skepticone 11/14/17 11:12:57 AM
#3957   Well the crooks are getting ready to do golfblues 11/14/17 10:55:12 AM
#3956   radly...Where is that info taken from? I would skepticone 11/14/17 09:29:13 AM
#3955   I bought this stock at the very start. Princes 11/13/17 10:05:51 PM
#3954   WOW $43 price target radly 11/13/17 07:29:32 PM
#3953   clay link doesn't seem to work berta 11/13/17 05:45:37 PM
#3952   * * $EKSO Video Chart 11-13-17 * * ClayTrader 11/13/17 04:48:57 PM
#3951   I can confirm Ret's find (excellent find Ret)! Bobby Marinov 11/13/17 04:06:37 PM
#3950   I did same sold the shares we got packerfan9 11/13/17 02:14:57 PM
#3949   I have a sell order in for a golfblues 11/13/17 12:41:28 PM
#3948   @ Billyp54...I think so, just hoping it's not skepticone 11/13/17 11:58:22 AM
#3947   WELL DONE berta 11/13/17 11:03:14 AM
#3946   Just curious, at what price did you jump skepticone 11/13/17 10:59:56 AM
#3945   As I stated in a post some time skepticone 11/13/17 10:55:46 AM
#3944   $2.60'S!! [SMART MONEY] 11/13/17 09:48:06 AM
#3943   [YT]Z_pdZ1LW5iw[/YT] [SMART MONEY] 11/13/17 08:51:39 AM
#3942   Well said. I totally agree! Some of the golfblues 11/13/17 08:41:40 AM
#3941   While I am happy about this nice run, skepticone 11/13/17 08:14:07 AM
#3940   I’ve been in this for almost 3 years Billyp54 11/13/17 06:33:10 AM
#3939   good stuff RT thanks berta 11/12/17 10:00:44 AM
#3938   I noticed something on the SOFWERX website today: Rhetorical 11/11/17 11:42:08 PM